Genetic Technologies Limi... (GENE)
NASDAQ: GENE
· Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM
Genetic Cash Flow Statement
Financials in AUD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Net Income | -5.6M | n/a | -6.42M | n/a | -3.15M | n/a | -5.46M | n/a | -3.25M | n/a | -3.88M | n/a | -3.6M | n/a | -3.48M | n/a |
Depreciation & Amortization | 254.22K | n/a | 280.67K | n/a | 173.2K | n/a | 330.19K | n/a | 364.09K | n/a | 214.58K | n/a | 337.11K | n/a | 141.11K | n/a |
Stock-Based Compensation | 124.18K | n/a | n/a | n/a | 253.45K | n/a | n/a | n/a | 437.51K | n/a | n/a | n/a | 113.31K | n/a | 601.27K | n/a |
Other Working Capital | 111.98K | n/a | n/a | n/a | -294.15K | n/a | n/a | n/a | 221.18K | n/a | n/a | n/a | -143.83K | n/a | n/a | n/a |
Other Non-Cash Items | -416.33K | n/a | 2.24M | n/a | 1.18M | n/a | 2.41M | n/a | 2.11M | n/a | -456.5K | n/a | 844.77K | n/a | -999.42K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | -290.96K | n/a | n/a | n/a | 1.07M | n/a | n/a | n/a | -517.02K | n/a | n/a | n/a |
Change in Working Capital | -31.39K | n/a | n/a | n/a | 164.24K | n/a | n/a | n/a | -2.24M | n/a | n/a | n/a | -270.51K | n/a | n/a | n/a |
Operating Cash Flow | -5.67M | n/a | -3.9M | n/a | -1.8M | -1.03M | -2.72M | n/a | -1.5M | n/a | -4.12M | n/a | -2.58M | -1.08M | -3.73M | n/a |
Capital Expenditures | -4.73K | -1K | -7K | -21K | -12K | -1K | -114 | -3K | -79.79K | n/a | -25K | -2K | -60K | -26K | -106K | -450 |
Cash Acquisitions | n/a | n/a | n/a | n/a | -188 | n/a | -187 | -486K | -3K | n/a | 64.04K | -3.46M | -5.19K | n/a | 5.19K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 29.64K | n/a | 118.22K | n/a | 188.00 | n/a | 79.75K | n/a | 110.63K | n/a | -64.04K | n/a | 5.19K | n/a | -5.19K | n/a |
Investing Cash Flow | 24.92K | -1K | -7K | -21K | -12K | -1K | 79.45K | -489K | 27.84K | n/a | -25K | -3.46M | -60K | -26K | -106K | -450 |
Debt Repayment | n/a | n/a | -172.85K | n/a | -336.4K | n/a | -166.48K | n/a | n/a | n/a | -15.45K | n/a | 5.51K | n/a | -114.79K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3M | n/a | -2.23K | n/a | -64.06K | -852K | n/a | n/a | -253.15K | n/a | -15.99K | n/a | -473.14K | 7.54M | -786.65K | -790 |
Financial Cash Flow | 3M | 601K | -172.85K | n/a | 3.04M | 6.32M | -166.48K | n/a | -263.62K | n/a | -31.43K | n/a | -26K | 7.54M | -1.05M | 6.43K |
Net Cash Flow | -2.71M | 614K | -1.17M | -2.96M | -2.63M | 5.44M | -2.9M | -3.79M | 383K | 13.41M | -2.23M | -5.16M | -2.08M | 6.55M | -1.66M | 3.88K |
Free Cash Flow | -5.67M | -1K | -3.9M | -21K | -1.81M | -1.03M | -2.72M | -3K | -1.58M | n/a | -4.15M | -2K | -2.64M | -1.11M | -3.84M | -450 |